Clincosm LogoSign in Get a demo

hyperlipidemia

Showing 26 - 50 of 337
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypercholesterolemia, Hyperlipidemia, Vitamin Deficiency Trial in Durham (Fortified eggs, Intermittent fasting, Non-egg

Recruiting
  • Hypercholesterolemia
  • +3 more
  • Fortified eggs
  • +3 more
  • Durham, North Carolina
    Duke University Health System
Dec 10, 2021

Hyperlipidemia Trial in China (K-877 0.1 mg tablet, Fenofibrate 200 mg capsule, Placebo tablet)

Recruiting
  • Hyperlipidemia
  • K-877 0.1 mg tablet
  • +3 more
  • Anhui, China
  • +32 more
Dec 8, 2021

Hyperlipidemia Trial in Changsha, Chengdu, Beijing (100 mg inclisiran sodium (equivalent to 94.5 mg inclisiran), Placebo, 300 mg

Completed
  • Hyperlipidemia
  • 100 mg inclisiran sodium (equivalent to 94.5 mg inclisiran)
  • +2 more
  • Changsha, Hunan, China
  • +2 more
Dec 2, 2021

Hyperlipidemia Trial run by the (MCT oil + Butter in Coffee)

Recruiting
  • Hyperlipidemia
  • MCT oil + Butter in Coffee
  • Bethesda, Maryland
    Walter Reed National Military Medical Center
Oct 5, 2021

Heart Failure, Hypertension, Diabetes Trial in Boston (Virtual Visit)

Terminated
  • Heart Failure
  • +5 more
  • Virtual Visit
  • Boston, Massachusetts
    Brigham and Women's Hospital
Sep 15, 2021

Diabetes, Hyperlipidemia, Hypertension Trial in United States (CVRS Intervention)

Completed
  • Diabetes
  • +3 more
  • CVRS Intervention
  • Gainesville, Florida
  • +17 more
Jul 22, 2021

Dietary Sources of Lysophospholipids

Terminated
  • Obesity
  • +2 more
    • Lexington, Kentucky
      University of Kentucky Dept of Cardiology
    Jul 20, 2021

    Vitamin D Retrospective Study and Role With Disease

    Active, not recruiting
    • Vitamin D Status
    • +4 more
    • Vitamin D
    • Baltimore, Maryland
      Baltimore VAMC
    Jul 19, 2021

    Cardiovascular Disease, Hypertension, Hyperlipidemia Trial in United States (FDA approved drugs to treat blood pressure and

    Completed
    Has Results
    • Cardiovascular Disease
    • +4 more
    • FDA approved drugs to treat blood pressure and cholesterol
    • Chinle, Arizona
    • +3 more
    Jun 15, 2021

    Hyperlipidemia Trial in Philadelphia (Aspirin, Placebo, Niacin)

    Completed
    Has Results
    • Hyperlipidemia
    • Philadelphia, Pennsylvania
      University of Pennsylvania Hospital
    Jun 21, 2021

    Hypertension, Hyperlipidemia Trial in Mobile (Polypill (atorvastatin, amlodipine, losartan, and hydrochlorothiazide))

    Completed
    Has Results
    • Hypertension
    • Hyperlipidemia
    • Polypill (atorvastatin, amlodipine, losartan, and hydrochlorothiazide)
    • Mobile, Alabama
      Franklin Primary Health Center
    Apr 18, 2021

    Hyperlipidemia, Dyslipidemia Trial in United States (NK-104-CR, Livalo® IR, Placebo (for NK-104-CR))

    Withdrawn
    • Hyperlipidemia
    • Dyslipidemia
    • Foley, Alabama
    • +68 more
    May 6, 2021

    Hyperlipidemia, Dyslipidemia Trial in United States (NK-104-CR, Placebo, Livalo)

    Withdrawn
    • Hyperlipidemia
    • Dyslipidemia
    • Beverly Hills, California
    • +44 more
    May 6, 2021

    Cardiovascular Diseases, Hyperlipidemia, Obesity Trial in Charleston, Columbia (Physical Activity Group, Standard Care Group)

    Completed
    • Cardiovascular Diseases
    • +2 more
    • Physical Activity Group
    • Standard Care Group
    • Charleston, South Carolina
    • +1 more
    Apr 27, 2021

    Hyperlipidemia, NAFLD Trial in United States (VK2809, Placebo)

    Completed
    • Hyperlipidemia
    • NAFLD
    • Chandler, Arizona
    • +18 more
    Apr 22, 2021

    Hyperlipidemia, Hypertension Trial in Hong Kong (Shanzha Fruit drink or drink)

    Completed
    • Hyperlipidemia
    • Hypertension
    • Shanzha Fruit drink or placebo drink
    • Hong Kong, Hong Kong
      The Chinese University of Hong Kong
    Apr 21, 2021

    Overweight and Obesity, NAFLD, Hyperlipidemia Trial in Changsha (ASC 41, ASC 41 Placebo)

    Completed
    • Overweight and Obesity
    • +2 more
    • ASC 41
    • ASC 41 Placebo
    • Changsha, Hunan, China
      Hunan provincial people's hospital
    Apr 6, 2021

    Healthy, NAFLD, Hyperlipidemia Trial in Changsha (ASC41 tablet)

    Completed
    • Healthy
    • +2 more
    • ASC41 tablet
    • Changsha, Hunan, China
      Hunan provincial people's hospital
    Apr 6, 2021

    Hyperlipidemia, Insulin Resistance, Type 2 Diabetes Trial in Stanford (Atorvastatin)

    Completed
    Has Results
    • Hyperlipidemia
    • +2 more
    • Stanford, California
      Stanford University School of Medicine
    Mar 11, 2021

    Acute Microvascular Changes With LDL Apheresis

    Completed
    Has Results
    • Hyperlipidemia
    • Plasmapharesis
    • Portland, Oregon
      Oregon Health & Science University
    Mar 5, 2021

    Compliance With Treatment For Patients With Hyperlipidemia

    Completed
    Has Results
    • Hyperlipidemia
    • Lipid Self Test
    • Akersberga, Sweden
    • +16 more
    Feb 17, 2021

    Hyperlipidemia, Diabetes, Type 2, Non-Insulin Dependent Diabetes Trial in Germany (Atorvastatin, Placebo)

    Terminated
    • Hyperlipidemia
    • +2 more
    • BAD Muenster AM Stein, Germany
    • +13 more
    Feb 17, 2021

    Hyperlipidemia Trial in Switzerland (Atorvastatin)

    Completed
    • Hyperlipidemia
    • Langenthal, BE, Switzerland
    • +19 more
    Feb 17, 2021

    Hypertension, Hyperlipidemia Trial in Worldwide (Amlodipine/atorvastatin single pill)

    Completed
    • Hypertension
    • Hyperlipidemia
    • Amlodipine/atorvastatin single pill
    • Buenos Aires, Argentina
    • +117 more
    Jan 26, 2021

    Hypertension, Hyperlipidemia Trial in Worldwide (Amlodipine/atorvastatin single pill)

    Completed
    • Hypertension
    • Hyperlipidemia
    • Amlodipine/atorvastatin single pill
    • Salzburg, Austria
    • +101 more
    Jan 26, 2021